DIGITALLY ENHANCED PHARMACEUTICALS™ (DEPs)
Dedicated to improving how patients feel and function.
Medical-grade, AI driven intelligence, disease-specific insight and beautiful patient experiences—designed to complement your therapy.
WHAT WE DO
From digital biomarkers to AI-driven patient insights.
Digitally Enhanced Pharmaceuticals™ (DEPs) add a continuous feedback layer around prescribed therapy—combining sensing, Software as a Medical Device and personalized experiences built for the people around each patient.
01
WEARABLE
Medical-grade sensing in a discreet, finger-worn ring designed to blend into daily life.
02
INTELLIGENCE
FDA-cleared software structures patient signals into disease-specific measures; AI-supported analytics surface patterns over time.
03
INSIGHTS
AI transforms longitudinal data into patient-specific insights and personalized experiences.
04
COMMUNITY
Shared context connects patients, caregivers and care teams around each patient journey.
OUR FIRST DEP JOURNEY: PARKINSON’S DISEASE.
Continuous. Intelligent. Personalized.
We are starting our DEP journey with Parkinson’s disease. The essara wearable ring and FDA-cleared disease-specific software create longitudinal context around each patient’s individual experience.
Personalization to a patient’s individual experience.
AN EXTENSIBLE DEP PLATFORM
Continuous data.
Smarter DEP programs.
Connected wearables capture what happens between visits. Approved algorithms structure the signal; AI surfaces patterns and personalizes patient experiences.
essara DEP INTELLIGENCE
From continuous signal to usable evidence.
Wearable data becomes disease-specific measurement, AI-supported insight and shared context around each patient journey.
01 / SENSE
Wearable data
Continuous signal
02 / STRUCTURE
SaMD
Reliable measures
03 / LEARN
AI insight
Patterns over time
04 / ACT
Decision making
Integrated decision context
A continuous digital layer, built around each patient journey
BUILT INTO BEAUTIFUL, PERSONALIZED EXPERIENCES
Personalized experiences.
Shared understanding.
Designed around each patient’s individual experience—bringing useful context to patients, care teams and therapy developers.
PATIENT EXPERIENCE
Individual context, reflection and support
CARE TEAM CONTEXT
Shared longitudinal context around each patient
THERAPY DEVELOPMENT
Population-level insight to support therapy development
THE NEXT PHASE
Our DEP journey starts in Parkinson’s disease.
Reach out to learn more and help shape what comes next.
We will follow up.